Cholinergic involvement and synaptic dynamin 1 expression in yokukansan-mediated improvement of spatial memory in a rat model of early alzheimer's disease

Phytotherapy Research

Volumn 27, Issue 7, 2013, Pages 966-972

  Uchida, Naoki ^a   Takasaki, Kotaro ^a   Sakata, Yuri ^a   Nogami, Ai ^a   Oishi, Hiroshi ^a   Watanabe, Takuya ^a   Shindo, Taro ^a   Egashira, Nobuaki ^b   Kubota, Kaori ^a   Katsurabayashi, Shutaro ^a   Mishima, Kenichi ^a   Fujiwara, Michihiro ^a   Nishimura, Ryoji ^a   Iwasaki, Katsunori ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Alzheimer's disease; Chinese herbal medicine; Dynamin 1; Hippocampus; Memory impairment; Yokukansan

Indexed keywords

ACETYLCHOLINE; DYNAMIN I; HERBACEOUS AGENT; POTASSIUM ION; UNCLASSIFIED DRUG; YOKUKANSAN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CHOLINERGIC SYSTEM; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DRUG EFFICACY; ENDOCYTOSIS; HIPPOCAMPUS; MALE; MAZE TEST; MEMORY DISORDER; NONHUMAN; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY; SYNAPSE VESICLE; TASK PERFORMANCE; TREATMENT DURATION; TREATMENT RESPONSE;

ALZHEIMER'S DISEASE; CHINESE HERBAL MEDICINE; DYNAMIN 1; HIPPOCAMPUS; MEMORY IMPAIRMENT; YOKUKANSAN;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; DYNAMIN I; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; ISCHEMIC ATTACK, TRANSIENT; MALE; MAZE LEARNING; MEMORY DISORDERS; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION;

ANIMALIA; RATTUS;

EID: 84879943926     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4818     Document Type: Article

References (30)

1. Choi B, Park YS, Cho NJ,. 2006. Agonist-induced internalization of the Caenorhabditis elegans muscarinic acetylecholine receptor GAR-3 in Chinese hamster ovary cells. Neurochem Res 31: 719-725.
2. Clark SG, Shurland DL, Meyerowits EM, Bargmann CI, van der Bliek AM,. 1997. A dynamin GTPase mutation causes a rapid and reversible temperature-inducible locomotion defect in C elegans. Proc Natl Acad Sci USA 94: 10438-10443.
3. DeKosky ST, Scheff SW,. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27: 457-464.
4. Dos Santos-Neto LL, de Vilhena Toledo MA, Medeiros-Souza P, de Souza GA,. 2006. The use of herbal medicine in Alzheimer's disease-a systematic review. Evid Based Complement Alternat Med 3: 441-445.
5. 2A receptors in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 32: 1516-1520.
6. Ferguson SM, Brasnjo G, Hayashi M, et al,. 2007. A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis. Science 316: 570-574.
7. Goto H, Satoh N, Hayashi Y, et al,. 2009 A Chinese herbal medicine, Tokishakuyakusan, reduces the worsening of impairments and independence after stroke. Evid Based Complement Alternat Med 2011: 194046. doi: 10.1093/ecam/nep026.
8. Hatip-Al-Khatib I, Egashira N, Mishima K, et al,. 2004. Determination of the effectiveness of compounds of herbal medicine Toki-Shakuyaku-San and fractions of Angekica acutiloba in improving the scopolamine-induced impairment of rat's spatial cognition in eight-armed radial maze test. J Pharmacol Sci 96: 33-41.
9. Ikarashi Y, Iizuka S, Imamura S, et al,. 2009. Effects of Yokukansan, a traditional Japanese medicine, on memory disturbance and behavior and psychological symptoms of dementia in thiamine-deficient rats. Biol Pharm Bull 32: 1701-1709.
10. Ikegami S,. 1994. Behavioral impairment in radial-arm maze learning and acetylcholine content of the hippocampus and cerebral cortex in aged mice. Behav Brain Res 65: 103-111.
11. Ito T,. 1997. Regulatory effect of yoku-kan-san-ka-chinpi-hange and saiko-ka-ryukotsu-borei- to on function of the central nervous system in mice. Prog Med 17: 823-830.
12. Iwasaki K, Maruyama M, Tomita N, et al,. 2005a. Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. J Clin Psychiatry 66: 1612-1613.
13. Iwasaki K, Satoh-Nakagawa T, Maruyama M, et al,. 2005b. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 66: 248-252.
14. May BH, Lit M, Xue CC, et al,. 2009. Herbal medicine for dementia: a systematic review. Phytother Res 23: 447-459.
15. Mizukami K, Asada T, Kinoshita T, et al,. 2009. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioral and psychological symptoms of dementia. Int J Neuropsychopharmacol 12: 191-199.
16. Monji A, Takita M, Samejima T, et al,. 2009. Effect of yokukansan on the behavior and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 33: 308-311.
17. 1 receptor. Pharmacol Biochem Behav 81: 616-625.
18. Nogami A, Sakata Y, Uchida N, et al,. 2011. Effects of yokukansan on anxiety-like behavior in a rat model of cerebrovascular dementia. J Nat Med 65: 275-281.
19. Okuda T, Konishi A, Misawa H, Haga T,. 2001. Substrate-induced internalization of the high-affinity choline transporter. J Neurosci 19: 14989-14997.
20. Shinno H, Inami Y, Inagaki T, Nakamura Y, Horiguchi J,. 2008. Effect of Yi-Gan-San on psychiatric symptoms and sleep structure at patients with behavior and psychological symptoms of dementia. Prog Neuropsychopharmacol Biol Psychiatry 32: 881-885.
21. Tabuchi M, Yamaguchi T, Iizuka S, Imamura S, Ikarashi Y, Kase Y,. 2009. Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease. J Ethnopharmacol 122: 157-162.c
22. Takeda A, Itoh H, Tamano H, Yuzuriha M, Oku N,. 2008. Suppressive effect of Yokukansan on excessive release of glutamate and aspirate in the hippocampus of zinc-deficient rats. Nutr Neurosci 11: 41-46.
23. Tateno M, Ukai W, Ono T, Saito S, Hashimoto E, Saito T,. 2008. Neuroprotective effects of Yi-Gan-San against beta amyloid-induced cytotoxicity on rat cortical neurons. Prog Neuropsychopharmacol Biol Psychiatry 32: 1704-1707.
24. Terasawa K, Shimada Y, Kita T, et al,. 1997. Choto-san in the treatment of vascular dementia. Phytomedicine 4: 15-22.
25. Terry AV Jr, Buccafuso JJ,. 2003. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306: 821-827.
26. Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J,. 2000. The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. Neurology 55: 1278-1283.
27. Uchida N, Egashira N, Iwasaki K, et al,. 2009. Yokukansan inhibits social isolation-induced aggression and Methamphetamine-induced hyperlocomotion in rodents. Biol Pharm Bull 32: 372-375.
28. Watanabe T, Iwasaki K, Ishikane S, et al,. 2008. Spatial memory impairment without apoptosis induced by the combination of beta-amyloid oligomers and cerebral ischemia is related to decreased acetylcholine release in rats. J Pharmacol Sci 106: 84-91.
29. Watanabe T, Iwasaki K, Takasaki K, et al,. 2010. Dynamin 1 depletion and memory deficits in rats treated with Aβ and cerebral ischemia. J Neurosci 9: 1908-1917.
30. Yao PJ, Zhu M, Pyun EI, et al,. 2003. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol Dis 12: 97-109.